



Suche nach Stichworten
Begriffe, Krankheiten, Einrichtungen u.v.m., verknüpft mit dem zuständigen Bereich.
Begriffe, Krankheiten, Einrichtungen u.v.m., verknüpft mit dem zuständigen Bereich.
Suche über die Einrichtungen
Im Menüpunkt "Übersicht" sind Einrichtungen unter verschiedenen Gesichtspunkten gruppiert: Kliniken, Abteilungen, Institute, Zentrale Einrichtungen und ähnliches.
Im Menüpunkt "Übersicht" sind Einrichtungen unter verschiedenen Gesichtspunkten gruppiert: Kliniken, Abteilungen, Institute, Zentrale Einrichtungen und ähnliches.
Original Papers |
|
| Arampatzidou, M., Mayer, K., Iolyeva, M.E., Asrat, S.G., Ravichandran, M., Gunther, T., Schule, R., Reinheckel, T., and Brix, K. (2011). Studies of intestinal morphology and cathepsin B expression in a transgenic mouse aiming at intestine-specific expression of Cath B-EGFP. Biol Chem 392, 983-993. |
PDF
|
| Bissinger, E.M., Heinke, R., Spannhoff, A., Eberlin, A., Metzger, E., Cura, V., Hassenboehler, P., Cavarelli, J., Schule, R., Bedford, M.T., et al. (2011). Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bioorg Med Chem 19, 3717-3731. |
|
| Gullotti, L., Czerwitzki, J., Kirfel, J., Propping, P., Rahner, N., Steinke, V., Kahl, P., Engel, C., Schule, R., Buettner, R., et al. (2011). FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer. Lab Invest. |
PDF
|
| Hauser, A.T., Bissinger, E.M., Metzger, E., Repenning, A., Bauer, U.M., Mai, A., Schule, R., and Jung, M. (2011). Screening Assays for Epigenetic Targets Using Native Histones as Substrates. J Biomol Screen. |
PDF
|
| Rafael, M.S., Laize, V., Bensimon-Brito, A., Leite, R.B., Schule, R., and Cancela, M.L. (2011). Four-and-a-half LIM domains protein 2 (FHL2) is associated with the development of craniofacial musculature in the teleost fish Sparus aurata. Cell Mol Life Sci. |
PDF
|
| Schildhaus, H.U., Riegel, R., Hartmann, W., Steiner, S., Wardelmann, E., Merkelbach-Bruse, S., Tanaka, S., Sonobe, H., Schule, R., Buettner, R., et al. (2011). Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum Pathol 42, 1667-1675. |
PDF
|
| Nair, S S, Nair, B C, Cortez, V, Chakravarty, D, Metzger, E, Schüle, R, Brann, D W, Tekmal, R R, Vadlamudi, R K (2010). PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity. EMBO reports 11, 438-44. |
PDF |
| Metzger E, Imhof A, Patel D, Kahl P, Hoffmeyer K, Friedrichs N, Müller JM, Greschik H, Kirfel J, Ji S, Kunowska N, Beisenherz-Huss C, Günther T, Buettner R, Schüle R. (2010). Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 464, 792-6. |
PDF |
| Heyne K, Willnecker V, Schneider J, Conrad M, Raulf N, Schüle R, Roemer K (2010). NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle. Nucleic Acids Res. |
PDF |
| Lim S, Janzer A, Becker A, Zimmer A, Schüle R, Buettner R, Kirfel J (2010). Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31, 512-20. |
PDF |
| Schulte, EC, Slawik, H, Schüle, R, Gunther, T, Hüll, M (2009). Alterations in excitotoxicity and prostaglandin metabolism in a transgenic mouse model of Alzheimer's disease. Neurochem Int. 55, 689-96. |
PDF |
| Schulte, JH, Lim, S, Schramm, A, Friedrichs, N, Koster, J, Versteeg, R, Ora, I, Pajtler, K, Klein-Hitpass, L, Kuhfittig-Kulle, S, Metzger, E, Schüle, R, Eggert, A, Buettner, R, Kirfel, J. (2009). Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res. 69, 2065-71. |
PDF |
| Zhao Y, Lang G, Ito S, Bonnet J, Metzger E, Sawatsubashi S, Suzuki E, Le Guezennec X, Stunnenberg HG, Krasnov A, Georgieva SG, Schüle R, Takeyama K, Kato S, Tora L, Devys D. (2008). A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Molecular Cell. 29, 92-101. |
PDF |
| Metzger E, Yin N, Wissmann M, Kunowska N, Fischer K, Friedrichs N, Patnaik D, Higgins JM, Potier N, Scheidtmann KH, Buettner R, Schüle R. (2008). Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat Cell Biol. 10, 53-60. |
PDF |
| Spira D, Stypmann J, Tobin DJ, Petermann I, Mayer C, Haggemann S, Vasiljeva O, Gunther T, Schule R, Peters C, Reinheckel T. (2007). Cell type-specific functions of the lysosomal protease cathepsin L in the heart. J Biol Chem. J Biol Chem. 282, 37045-37052. |
PDF |
| Spannhoff A, Machmur R, Heinke R, Trojer P, Bauer I, Brosch G, Schule R, Hanefeld W, Sippl W, Jung M. (2007). A novel arginine methyltransferase inhibitor with cellular activity. Bioorg Med Chem Lett. 17, 4150-3. |
PDF |
| Spannhoff A, Heinke R, Bauer I, Trojer P, Metzger E, Gust R, Schule R, Brosch G, Sippl W, Jung M. (2007). Target-based approach to inhibitors of histone arginine methyltransferases. Bioorg J Med Chem. 50, 2319-25. |
PDF |
| Nair SS, Guo Z, Mueller JM, Koochekpour S, Qiu Y, Tekmal RR, Schule R, Kung HJ, Kumar R, Vadlamudi RK. (2007). Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein. Mol Endocrinol. 21, 613-24. |
PDF |
| Wixler V, Hirner S, Muller JM, Gullotti L, Will C, Kirfel J, Gunther T, Schneider H, Bosserhoff A, Schorle H, Park J, Schule R, Buettner R. (2007). Deficiency in the LIM-only protein Fhl2 impairs skin wound healing. J Cell Biol. 177, 163-72. |
PDF |
| Wissmann M, Yin N, Mueller JM, Greschik H, Fodor BD, Jenuwein T, Vogler C, Schneider R, Guenther T, Buettner R, Metzger E, Schuele R (2007). Co-operative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol. 9, 347-353. |
PDF |
| Nair SS, Guo Z, Müller JM, Koochekapour S, Qiu Y, Tekmal RR, Schüle R, Kung HJ, Kumar R, Vadlamundi RK. (2007) PELP1/MNAR enhances androgen receptor functions through LIM-only coactivator FHL2. Mol Endocrinol. 21, 613-624. |
PDF |
| Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schuele R, Buettner R (2006). Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer Recurrence. Cancer Res. 66, 11341-11347. |
PDF |
| Bagheri-Fam S, Barrionuevo F, Dohrmann U, Gunther T, Schule R, Kemler R, Mallo M, Kanzler B, Scherer G. (2006). Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern. Dev. Biol. 291, 382-97. |
PDF |
| Gabriel B, Fischer DC, Orlowska-Volk M, zur Hausen A, Schuele R, Muller JM and Hasenburg A (2006). Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study. J. Soc. Gynecol. Investig. 13, 69-75. |
PDF |
| Hublitz P, Kunowska N, Mayer UP, Muller JM, Heyne K, Yin N, Fritzsche C,Poli C, Miguet L, Schupp IW, van Grunsven LA, Potiers N, van Dorsselaer A,Metzger E, Roemer K, Schuele, R. (2005). NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev. 19, 2912-24. |
PDF
|
| Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schuele, R. (2005). LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature. 437, 436-439. |
PDF
|
| Gunther T, Poli C, Muller JM, Catala-Lehnen P, Schinke T, Yin N, Vomstein S, Amling M, Schuele, R. (2005). Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J. 24, 3049-56. |
PDF
|
| Bai, S., Kitaura, H., Zhao, H., Chen, J., Muller, J.M., Schuele, R., Darnay, B., Novack, D.V., Ross, F.P. and Teitelbaum. S.L. (2005). FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J. Clin. Invest. 115, 2742-2751. |
PDF
|
| Purcell, N.H., Darwis, D., Bueno, O.F., Muller, J.M., Schuele, R. and Molkentin, J.D. (2004). Extracellular signal-regulated kinase 2 (ERK2) interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol. Cell. Biol. 24, 1081-1095. |
PDF
|
| Gabriel B, Mildenberger S, Weisser CW, Metzger E, Gitsch G, Schuele, R , Mueller JM (2004). Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res. 24, 921-7. |
PDF
|
| Samson, T., Smyth, N., Janetzky, S., Wendler, O., Mueller, J.M., Schuele, R., von der Mark, H., von der Mark, K. and Wixler, V. (2004). The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor. J. Biol. Chem. 279, 28641-28652. |
PDF
|
| Hagemann, S., Guenther, T., Dennemärker, J., Lohmueller, T., Brömme, D., Schuele, R., Peters, C. and Reinheckel,T. (2004). The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles. Eur. J. Cell. Biol. 83, 775-780. |
PDF
|
| Oehler, MK., Greschik, H., Fischer, DC., Tong, X., Schuele, R. and Kieback, DG. (2004). Functional characterization of somatic point mutations of the human estrogen receptor alpha in adenomyosis uteri. Mol. Hum. Reprod. 12, 853-860. |
PDF
|
| Philippar U, Schratt G, Dieterich C, Muller JM, Galgoczy P, Engel FB, Keating MT, Gertler F, Schuele, R., Vingron M, Nordheim A. (2004). The SRF Target Gene Fhl2 Antagonizes RhoA/MAL-Dependent Activation of SRF. Mol. Cell. 16, 867-80. |
PDF
|
| Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D, Schule R. (2003). All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat. Struct. Biol. 10, 820-825. |
PDF
|
| Metzger E, Muller JM, Ferrari S, Buettner R, Schuele, R. (2003). A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J. 15, 270-280. |
PDF
|
| Du, X., Hublitz, P., Guenther, T., Wilhelm, D., Englert, C. and Schuele, R. (2002). The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. Biochimica et Biophysica Acta. 1577, 93-101. |
PDF
|
| Conceicao, N., Henriques, N.M. , Marc C.P., Ohresser, M.C.P., Hublitz, P., Schuele, R. and Cancela, L.M. (2002). Molecular cloning of the MGP gene from Xenopus laevis: functional analysis of the promoter identifies a calcium sensitive region required for basal activity. Eur. J. Biochem. 269, 1947-1956. |
PDF
|
| Mueller, J.M., Metzger, E., Greschik, H., Bosserhoff, A-K., Mercep, L., Buettner, R. and Schuele, R. (2002). The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J. 21, 736-748. |
PDF
|
| Stehlin C, Wurtz JM, Steinmetz A, Greiner E, Schuele R., Moras D, Renaud JP. (2001). X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J. 20, 5822-5831. |
PDF
|
| Greiner, E., Kirfel, J., Greschik, H., Huang, D., Becker, P., Kapfhammer, J.P. and Schuele, R. (2000). Differential ligand-dependent protein-protein interactions between nuclear receptors and a neuronal-specific cofactor. Proc. Natl. Acad. Sci. USA 97, 7160-7165. |
PDF
|
| Mueller, J.M., Isele, U., Metzger, E., Rempel, A., Moser, M., Pscherer, A., Breyer, T., Holubarsch, C., Buettner, R. and Schuele, R. (2000) FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19, 359-369. |
PDF
|
| Dörflinger, U., Pscherer, A., Moser, M., Ruemmele, P., Schuele, R. and Buettner, R. (1999) Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain. Mol. Cell. Biol. 19, 3736-3747. |
PDF
|
| Greschik, H., Wurtz, J.-M., Hublitz, P., Köhler, F., Moras, D. and Schuele, R. (1999) Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor GCNF. Mol. Cell. Biol. 19, 690-703. |
PDF
|
| Pfitzner, E., Kirfel, J., Becker, P., Rolke, A. and Schuele, R. (1998) Physical interaction between retinoic acid receptor and the oncoprotein Myb inbhibits retinoic acid dependent transactivation. Proc. Natl. Acad. Sci. USA 95, 5539-5544. |
PDF
|
| Kirfel, J., Kelter, M., Cancela, L.M., Price, P. and Schuele, R. (1997) Identification of a novel negative retinoic acid receptor response element in the promotor of the human matrix Gla protein gene. Proc. Natl. Acad. Sci. USA 94, 2227-2232. |
PDF
|
| Pscherer, A., Dörflinger, U., Kirfel, J., Gawlas, K., Rueschoff, J., Buettner, R. and Schuele, R. (1996) The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J. 15, 6680-6690. |
|
| Greiner, E., Kirfel, J., Dörflinger, U., Greschik, H., Becker, P., Mercep, A. and Schuele, R. (1996) Functional analysis of retinoid Z receptor b, a brain-specific nuclear orphan receptor. Proc. Natl. Acad. Sci. USA 93, 10105-10110. |
PDF
|
| Pfitzner, E., Becker, P., Rolke, A. and Schuele, R. (1995) Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions. Proc. Natl. Acad. Sci. USA 92, 12265-12269. |
PDF
|
| Moser, M., Imhof, A., Pscherer, A., Bauer, R., Amselgruber, W., Sinowatz, F., Hofstädter, F., Schuele, R. and Buettner, R. (1995) Cloning and characterization of a second AP-2 transcription factor: AP-2b. Development 121, 2779-2788. |
PDF
|
| Rohrer, R., Raulf, F., Bruns, Ch., Hofstädter, F, Buettner, R. and Schuele, R. (1993) Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. USA 90, 4196-4200. |
PDF
|
| Schuele, R., Pundi, R., Yang, N., Kliewer, S., Bolado, J., Verma, I.M. and Evans, R.M. (1991) Retinoic acid is a negative regulator of AP-1 responsive genes. Proc. Natl. Acad. Sci. USA 88, 6092-6096. |
|
| Yang, N., Schuele, R., Mangelsdorf, D.J. and Evans, R.M. (1991) Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. Proc. Natl. Acad. Sci. USA 88, 3559-3563. |
|
| Schuele, R., Pundi, R., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M. and Evans, R.M. (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62, 1217-1226. |
|
| Schuele, R., Umesono, K., Mangelsdorf, D., Bolado, J., Pike, W.J. and Evans, R.M. (1990). Jun/Fos and receptors for vitamin A and D recognize a common response element in the human osteocalcin gene. Cell 61, 497-504. |
|
| Schuele, R. (1988) Hormonal regulation of the rat tryptophan oxygenase gene. Intemann Press, Muenchen. |
|
| Schuele, R., Muller, M., Kaltschmidt, Ch. and Renkawitz, R. (1988) Many transcription factors interact synergistically with steroid receptors. Science 242, 1418-1420. |
|
| Schuele, R., Muller, M., Otzuka-Murakami, H. and Renkawitz, R. (1988) Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature 322, 87-90. |
|
| Danesch, U., Gloss, B., Schmid, W., Schuetz, G., Schuele, R. and Renkawitz, R. (1987) Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid responsive elements. EMBO J. 6, 625-630. |
|





